Management Approach
This patient has impaired fasting glucose (IFG) with normal postprandial glucose, and the anxiety and constant hunger pain are likely separate issues requiring concurrent management rather than being directly caused by the borderline glucose elevation.
Addressing the Impaired Fasting Glucose
Your patient's fasting glucose of 105 mg/dL meets the definition of IFG (100-125 mg/dL), placing them in the prediabetes category 1. This represents an intermediate metabolic state with increased risk for progression to diabetes and cardiovascular disease 1.
Primary intervention should focus on lifestyle modification:
- Target 5-7% body weight loss if overweight (BMI ≥25 kg/m²) 2, 3
- Prescribe 150 minutes per week of moderate-intensity aerobic exercise (such as brisk walking), spread over at least 3 days with no more than 2 consecutive days without exercise 4
- These lifestyle interventions are more effective than medications for preventing diabetes progression 2, 3
Medication consideration: While metformin or acarbose can delay diabetes onset, they are less effective than lifestyle changes and should be reserved for patients who cannot achieve lifestyle goals 3. Given the normal postprandial glucose, pharmacotherapy is not indicated at this time.
Follow-up testing: Repeat fasting glucose or consider A1C testing at 3-year intervals minimum, or more frequently if additional risk factors are present 1, 5.
Addressing the Anxiety and Hunger Pain
The anxiety and constant hunger require separate evaluation and are unlikely to be directly caused by a fasting glucose of 105 mg/dL, which is only minimally elevated.
For anxiety symptoms:
- Screen using validated anxiety measures 6
- The 2019 and 2025 diabetes guidelines recommend screening for anxiety in patients with diabetes, and this principle applies to prediabetes given the psychological burden of metabolic concerns 7, 6
- If anxiety interferes with daily functioning or quality of life, refer to a qualified behavioral health professional 6
- Consider whether the patient has developed food-related anxiety or health anxiety related to their glucose levels 8
For constant hunger pain:
This symptom pattern warrants consideration of several possibilities:
Functional gastrointestinal disorder: The combination of anxiety and hunger pain suggests possible irritable bowel syndrome (IBS) or functional dyspepsia. If gastrointestinal symptoms are prominent, consider:
Reactive hypoglycemia vs. idiopathic postprandial syndrome: Although postprandial glucose is normal, if the patient experiences symptoms specifically after meals:
- True postprandial hypoglycemia is unlikely given normal 2-hour glucose
- Consider idiopathic postprandial syndrome (hypoglycemic-like symptoms without biochemical hypoglycemia) 9
- Continuous glucose monitoring could correlate symptoms with actual glucose levels 9
- Dietary modification: high-protein, high-fiber, low-carbohydrate meals with frequent small feedings 9
Medication or metabolic causes: Review any medications that could affect hunger or glucose metabolism
Integrated Management Strategy
The optimal approach addresses both issues concurrently:
- Lifestyle intervention for IFG (primary focus for metabolic health and long-term outcomes)
- Anxiety screening and treatment if symptoms are interfering with function
- Dietary counseling that addresses both glucose management and hunger symptoms:
Common pitfall to avoid: Do not attribute the anxiety and hunger pain solely to the minimally elevated fasting glucose. A fasting glucose of 105 mg/dL does not cause symptomatic hypoglycemia or constant hunger. These symptoms require independent evaluation and management.
If anxiety is moderate to severe: Consider referral to behavioral health before implementing complex dietary interventions, as psychological symptoms can interfere with adherence to lifestyle modifications 8. SSRIs may be appropriate if a mood or anxiety disorder is diagnosed, and these do not adversely affect glucose metabolism 8.